Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PPD, a contract research organization, has expanded its post-approval drug safety expertise in epidemiology and risk management through a strategic alliance with World Health Information Science Consultants, an epidemiology and drug-safety organization based in Wellesley, Massachusetts.
Subscribe to our email newsletter
As part of the agreement, the two companies will jointly market their services to biomedical companies, insurers and government agencies worldwide. World Health Information Science Consultants (WHISCON) will draw upon PPD’s experience in large drug studies, both pre- and post-approval.
In turn, PPD will leverage WHISCON’s client relationships and global safety expertise in conducting epidemiology, risk management, pharmacovigilance, and observational and database studies.
Fred Eshelman, CEO of PPD, said: “Epidemiology is playing a larger, more important role in understanding and evaluating risks related to drug safety. Our agreement with WHISCON will enhance our ability to help clients identify and manage the benefits and risks of their marketed products.”